Precision and personalized medicine: deals decreased significantly in clinical trials in H2 2021
Deals relating to precision and personalized medicine have seen a decrease of 54.1% from H2 2020 to H2 2021.
By
Deals relating to precision and personalized medicine have seen a decrease of 54.1% from H2 2020 to H2 2021.
ByAdvancements in the medical device field have enabled more and more patients to improve their quality of life and regain…
Thank you for subscribing to Clinical Trials Arena